{
  "abstract": "Introduction Historically, patients at the Royal Hospital for Children diagnosed with obstructive sleep apnoea (OSA) were established on Bi-level Positive Airway Pressure (BiPAP). Although successful, the establishment process required multi-night inpatient stays to titrate pressures and ensure patient comfort. Recently, our service transitioned to using Auto Continuous Positive Airway Pressure (AutoCPAP) for the adolescent population. Our primary objective was to evaluate whether using AutoCPAP reduced the duration of inpatient stays compared to BiPAP. Our secondary objective was to compare the costs associated with establishing patients on AutoCPAP versus BiPAP and assess any differences in patient compliance with therapy.Methods This retrospective study compared the length of hospital stay for patients initiated on Airsense 11 AutoCPAP (n=6) versus age-matched controls initiated on BiPAP (Stellar 100 or Lumis 150; n=6). The cohort included individuals with Down Syndrome and obesity. To investigate our secondary aim, the cost analysis factored in the device price, equipment for sleep studies, and the cost of overnight hospital stays. Compliance was monitored 4 weeks after establishment.Results Patients initiated on AutoCPAP demonstrated a shorter median hospital stay compared to the BiPAP control group (1 vs. 2 nights). Among patients on AutoCPAP, four required a single-night hospital stay, while two stayed for two nights; the latter was attributed to poor sleep on the first night and parental confidence with the device. In contrast, most patients initiated on BiPAP required longer stays: five remained for two nights and one for three nights, primarily to allow for pressure titration. The total establishment cost for the AutoCPAP group was £11,760 lower than that of the BiPAP group. Compliance rates showed no significant difference between the two groups four weeks post-establishment. Table 1Conclusion Establishing patients onto AutoCPAP reduces median hospital stay compared to BIPAP, which directly increases bed capacity for diagnostic sleep studies and alleviates hospital winter pressures. This shift also facilitates notable cost savings while demonstrating no significant difference in short-term compliance. Future research should focus on a larger sample size and whether these compliance trends persist over an extended follow-up period.Abstract P36 Table 1",
  "authors": [
    {
      "affiliations": [
        "Royal Hospital for Children, Glasgow, United Kingdom"
      ],
      "name": "Amy Hunt"
    },
    {
      "affiliations": [
        "Royal Hospital for Children, Glasgow, United Kingdom"
      ],
      "name": "Elise Buchan"
    },
    {
      "affiliations": [
        "Royal Hospital for Children, Glasgow, United Kingdom"
      ],
      "name": "Paul Burns"
    },
    {
      "affiliations": [
        "Royal Hospital for Children, Glasgow, United Kingdom"
      ],
      "name": "Scott Tart"
    },
    {
      "affiliations": [
        "Royal Hospital for Children, Glasgow, United Kingdom"
      ],
      "name": "Jonathan Twynam-Perkins"
    },
    {
      "affiliations": [
        "Royal Hospital for Children, Glasgow, United Kingdom"
      ],
      "name": "Ross Langley"
    }
  ],
  "title": "P36 A comparative analysis of autoCPAP and BIPAP establishment in children with OSA",
  "uid": "8e50d298-c80f-5ca5-b815-f00d201e6d21"
}